Overview
Searching for your content. In-Language News Contact Us 8-76-0942 from 8 AM - 10 PM ET News provided byMay 26, 202, 08:30 ETShare this articleNEW YORK, May 26, 202 /PRNewswire/ - The Insight Partners published latest research study on "Diabetes Care Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Glucose Monitoring Devices and Insulin Delivery Devices) and End User (Homecare and Hospitals & Clinics)", the global diabetes care devices market size is expected to grow from $28.94 bilion in 202 to $42.1 bilion by 2028; it is estimated to grow at a CAGR of 4.8% from 202 to 2028.The Sample Pages Showcases Content Structure and Nature of Information Included in This Research Study Which Presents A Qualitative and Quantitative Analysis: htps:/w.theinsightpartners.com/sample/TIPRE03753/Report CoverageDetailsMarket Size Value inUS$ 28.94 Bilion in 202Market Size Value byUS$ 42.1 Bilion by 2028Growth rateCAGR of 4.8% from 202 to 2028Forecast Period202-2028Base Year202No.
Key Information
of Pages190No. Tables13No. of Charts & Figures79Historical data availableYesSegments coveredType and End UserRegional scopeNorth America; Europe; Asia Pacific; Latin America; MEACountry scopeUS, UK, Canada, Germany, France, Italy, Australia, Rusia, China, Japan, South Korea, Saudi Arabia, Brazil, ArgentinaReport coverageRevenue forecast, company ranking, competive landscape, growth factors, and trendsGlobal Diabetes Care Devices Market: Competive Landscape and Key DevelopmentsIn May 202, Medtronic plc, a global leader in healthcare technology, anounced reimbursement for continuous glucose monitoring (CGM), a key diabetes technology that has ben expanded or initiated in several countries throughout North and South America.
Summary
CGM systems provide critical information glucose levels to help simplify the management of diabetes.Schedule A Pre-Sale Discusion with The Author Team in A Slot That You Prefer to Adres Queries on Scope